iTeos Therapeutics, Inc.

ITOSNASDAQHealthcare

$10.15

+$0.02(+0.20%)

Market Cap$448684810

P/E Ratio—

52W High$17.63

52W Low$4.8

Avg Volume1.3M

Open$10.15

Beta1.49

Employees Ownership Insider Trades

iTeos Therapeutics, Inc. (ITOS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ITOS · as of Mar 5, 2025

Latest filing snapshot

173

+16+10.19%vs prior year

iTeos Therapeutics, Inc. (ITOS) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2024-12-31·Full-time · Global

Total Employees

173

Change (1Y)

+16

Growth % (1Y)

+10.19%

Revenue / Employee

$202.3K

Net Income / Employee

$-777.0K

Market Cap

$449M

ITOS Employee Count

2020 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2025-03-05	2024-12-31	173	+16	+10.19%
2024-03-06	2023-12-31	157	+32	+25.60%
2023-03-15	2022-12-31	125	+31	+32.98%
2022-03-23	2021-12-31	94	+32	+51.61%
2021-03-24	2020-12-31	62	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ITOS

iTeos Therapeutics, Inc.YOU

173$449M #2

ORTX

Orchard Therapeutics plc

166$380M #3

GTHX

G1 Therapeutics, Inc.

Checkpoint Therapeutics, Inc.

24$368M

CLYM

Climb Bio, Inc.

17$734M

BCYP

Big Cypress Acquisition Corp.

N/A$425M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ITOS peer comparison

About ITOS employees

ITOS Employees · Headcount

iTeos Therapeutics, Inc. (ITOS) employee data is sourced from the annual SEC 10-K filing. As of 2024, iTeos Therapeutics, Inc. had 173 full-time employees globally. Full-time employees only. Global consolidated headcount.

iTeos Therapeutics, Inc. employs 173 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $202,312, reflecting the company's operational efficiency.

iTeos Therapeutics, Inc.'s workforce increased by 16 (10.19%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

iTeos Therapeutics, Inc.'s revenue per employee of $202,312 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ITOS Employees · 5 questions

As of the latest SEC 10-K filing (2024), iTeos Therapeutics, Inc. had 173 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

iTeos Therapeutics, Inc. employee counthow many employees does iTeos Therapeutics, Inc. haveITOS total employees 2024

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-03-05